|
|
| Vendredi 22/11/2013 |
| 08:00 | |
|
| 08:50 | |
Dr Lieven MEERPOEL
(JANSSEN R&D, Belgique) |
| 09:00 | |
Prof. David FAIRLIE
(UNIVERSITY OF QUEENSLAND, Brisbane, Australie) |
| 09:50 | |
Dr Jan HOFLACK
(ONCODESIGN, Dijon, France) |
| 10:40 | |
|
| 11:15 | |
Prof. Peter TIMMERMAN
(PEPSCAN THERAPEUTICS, Lelystad, Pays-bas) |
| 11:35 | |
Dr Horst KESSLER
(TECHNISCHE UNIVERSITÄT MÜNCHEN, Garching, Allemagne) |
| 12:25 | |
|
| 14:00 | |
Dr Hamid HOVEYDA
(EUROSCREEN, Woluwe-Saint-Lambert, Belgique) - (formerly at TRANZYME Pharma, Sherbrooke, Canada) |
| 14:50 | |
Prof. WAEL HOUSSEN
(UNIVERSITY OF ABERDEEN, Old Aberdeen, Royaume-uni) |
| 15:10 | |
Prof. Alexander DÖMLING
(UNIVERSITY OF GRONINGEN, Groningen, Pays-bas) |
| 15:30 | |
|
| 16:05 | |
Dr Daniel OBRECHT
(POLYPHOR, Allschwil, Suisse) |
| 16:55 | |
Dr Pierre RABOISSON
(JANSSEN PHARMACEUTICAL COMPANIES, Mechelen, Belgique) |
| 17:45 | |
|
|
